[
| E-mail
]
Contact: Andrew Thompsonandrew@landesbioscience.comLandes Bioscience
A long-term follow-up study (HPV-023; NCT00518336) shows the sustained efficacy, immunogenicity and safety of GlaxoSmithKline’s human papilloma virus (HPV) vaccine Cervarix. Women vaccinated with…
Sustained efficacy, immunogenicity, and safety for GlaxoSmithKline’s HPV vaccine
No comments:
Post a Comment